I dont know that BIT has been flogged to every major pharma or any pharma at all rmp6868,most major pharmas would want to see trials a little further advanced I'd guess.
For this type of biospec she is well priced with some milestone announcements coming over the next 6months.Bell Potter has done a in depth report lately thats worth a read on the Biotron website.The report was surprisingly detailed for a spec this size.
In short nothing is assured but this is the risky end of the market.GL Holders
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
0.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $2.654M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 49 | 31975625 | 0.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.3¢ | 14366964 | 19 |
View Market Depth
| Last trade - 16.30pm 18/07/2025 (20 minute delay) ? |
| BIT (ASX) Chart |
Day chart unavailable